Innovative Medicines Canada (IMC) – Updated Code of Ethical Practices

Updated Code Of Ethical Practices sets the bar higher

Ottawa, December 2, 2019 – Innovative Medicines Canada (IMC) today announced changes to its Code of Ethical Practices to ensure that the important working relationship between our industry and its external stakeholders continues to reflect the highest ethical standards.

“Trust and transparency are key to building strong, productive and mutually beneficial relationships with our partners. We have updated our Code of Ethical Practices to ensure our member companies continue to have a solid foundation on which to build trust with all stakeholders in the Canadian life science ecosystem,” said Pamela Fralick, President of Innovative Medicines Canada.

All IMC members agree to comply with Code of Ethical Practices as a condition of membership in the association. more….